Ranbaxy Laboratories has posted a 91.85 per cent fall in net profit at Rs 23.73 crore for the quarter ended June 30, 2008, while the revenue risen 21.73 per cent to Rs 1324.4 crore.
The expenditure of the company has shot up 40.57 per cent to Rs 1244.31 crore owing to Rs 191.39 crore foreign exchange loss and an aadditional expenditure of Rs 320.59 crore. The company lost Rs 29.23 crore in depreciation and amortisation.